Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers define link between eosinophils and asthma

17.09.2004


Mayo Clinic researchers have used a comparative genomic strategy to demonstrate a causative link between eosinophils, a rare type of white blood cell, and asthma. Their research shows that the presence of these unique blood cells is absolutely required for the development of asthma. The details of this animal-based study appear in the Sept. 17, 2004, issue of Science, the journal of the American Association for the Advancement of Science (AAAS).



For more than a century, scientists have known that eosinophils are often the dominant inflammatory cells present in the lungs of asthma patients, but the importance of these white blood cells has been poorly understood with some studies even discounting a role for these cells. This new study demonstrates that eosinophils are required for the mucus accumulation and the lung dysfunction associated with asthma.

Using the tools of genomics, Mayo Clinic researchers have engineered a mouse that is specifically devoid of eosinophils, but otherwise has a full complement of blood-derived cells. Disease symptoms in these transgenic mice were dramatically reduced, and in some cases completely eliminated, following exposure to an allergen that in normal animals leads to asthma.


The development of a unique and novel transgenic mouse model without eosinophils now permits a definitive assessment of a number of human diseases besides asthma that have been linked to this white blood cell, including allergic diseases, parasite infections and cancer.

"Demonstrating that the eosinophil, a rare and often ignored cell, is a central mediator in the inflammation associated with asthma is a very important finding," says James J. Lee, Ph.D., director, Special Animal Services Laboratory at Mayo Clinic in Scottsdale, Ariz. "The outcomes of this study suggest the possibility of developing novel therapies and pharmaceuticals to treat and/or prevent asthma."

The Study

Researchers at Mayo Clinic Scottsdale created genetically-engineered transgenic mice that selectively express a toxic "suicide" gene, diphtheria toxin A, in bone marrow stem cells that go on to become circulating eosinophils in the blood. As a result of the selective expression of this toxin, unique marrow stem cells are eliminated and eosinophils never appear in circulation. The resulting mice have a normal complement of all red and white blood cell types except they are uniquely devoid of eosinophils.

Lung disease studies were conducted by comparing the responses of these transgenic mice without eosinophils relative to normal animals that contain eosinophils following exposure to an airborne allergen that provoked symptoms characteristic of asthma.

Significance of the Discovery

This study clearly shows that eosinophil activities are important contributing factors leading to symptoms classically defined as hallmark features of asthma. Future medical genomics studies will seek to confirm these findings in asthma patients and to further define the role of eosinophils in human disease, thereby widening the understanding of the principle causes of asthma and leading to targeted therapeutic approaches previously dismissed or overlooked. Because no known human patients or naturally occurring mutations in the mouse have been reported to be deficient of eosinophils without other additional consequences, this transgenic mouse model represents an important opportunity to define unambiguously the specific role of eosinophils in many diseases.

Participants in the Study

In addition to Dr. James J. Lee, others involved in the research include Dawn Dimina; MiMi P. Macias, PhD; Sergei I. Ochkur, PhD; Michael P. McGarry, PhD; Katie R. O’Neill, PhD; Cheryl Protheroe; Ralph Pero; Thanh Nguyen, M.D.; Stephania A. Cormier, PhD; Elizabeth Lenkiewicz; Dana Colbert; Lisa Rinaldi; Steven J. Ackerman, PhD; Charles G. Irvin, PhD; and Nancy A. Lee, PhD.

Support

The research was supported by grants from the Mayo Foundation, the American Heart Association, and the National Institutes of Health.

Bob Nellis | EurekAlert!
Further information:
http://www.mayo.edu

More articles from Life Sciences:

nachricht Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex

nachricht New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>